From: Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
 | N. (%) |
---|---|
N. of patients | 30 (100) |
Histology: | Â |
---Epidermoid | 28 (93) |
---Mixed | 2 (7) |
Previous surgery: | Â |
---Palliative pleural decortications | 11 (37) |
---Extrapleural pneumonectomy | 6 (20) |
---Videothoracoscopy and pleurodesis | 3 (10) |
---Other | 1 (3) |
Never | 9 (30) |
Median age (years) (range) | 64.1 (35–78) |
Performance Status (ECOG): | Â |
---0 | 15 (50) |
---1 | 15 (50) |
Sex: | Â |
---Female | 7 (23) |
---Male | 23 (77) |
Stage at diagnosis (IMIG): | Â |
---II | 9 (30) |
---III | 8 (27) |
---IV | 12 (40) |
---Other | 1 (3) |
Combination of first-line chemotherapy: | Â |
---Cisplatin and pemetrexed | 21 (70) |
---Carboplatin and pemetrexed | 9 (30) |
Response to first-line treatment: | Â |
---Stable Disease | 15 (50) |
Partial Response | 15 (30) |